Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Appreciate your post here, jesse. As a veteran of biotech investing, you probably have leaned a lot--false starts, disappointing clinical trial results, and promising treatments flying under the radar.
The US has the most advanced biotech research because of our ability to raise capital on the public markets for these unproven (as of yet) treatments.
Orphan drugs are not abandoned in the US. They can find a way on to the market with the assistance of the FDA if given the chance to prove their efficacy.
I, too, tend towards biotechs in my higher risk portion of my portfolio. Just like to read the data, trade the swings and hold a core position for he long term if warranted.
Appreciate your post here, jesse. As a veteran of biotech investing, you probably have leaned a lot--false starts, disappointing clinical trial results, and promising treatments flying under the radar.
The US has the most advanced biotech research because of our ability to raise capital on the public markets for these unproven (as of yet) treatments.
Orphan drugs are not abandoned in the US. They can find a way on to the market with the assistance of the FDA if given the chance to prove their efficacy.
I, too, tend towards biotechs in my higher risk portion of my portfolio. Just like to read the data, trade the swings and hold a core position for he long term if warranted.
Thanks for the response, JL. i followed you here from the AMRN board. Appreciate everything you did there, sorry that subsequent events diluted your fantastic diligence and efforts to directly assist that company and it's investors for many years.
JL, This is indeed an interesting post for AMRN (Vascepa) users - 'and investors'.
JL will be among the 10 people in this world that knows most about Vasepa and 'the wonders' of EPA.
JL's story here - is 'A Sensational Example' of what Vascepa can do'.
He were for +10 years a major poster/investor in AMRN - but took of after the Law Cases pulled the stock down (couldn't handle the Law nonsense - he said).
--------------
But Vasepa 'Saved his Life' - that is essentially what he says here - and he will know why' - being the master example' of how effective this drug is' - times 8 purified EPA - patented encapsulated secured from oxidation.
Thanks for this post - that will be noticed by the many 'long time' posters on this board - who knows JL very well.
Thanks Jesse - and you be continued well - protected by Vascepa :)
Jasbg
new2theparty...
I am a good example of how important the inflammatory system is in determining the course of the disease...I am a poster child for a guy who should have been finished by the virus..I have recently reached 80 years had a heart attack four years ago and had a highly lethal "saddleback) pulmonary embolus three years ago...Well in Feb of this year I tested positive for COV-19...
But rather than a serious course...I had only a temp of 101F for one day. No further fever. and had a runny nose, which cleared up with a nasal spray. I was a little tired for a couple of days...but was perfectly OK by day four...
Why was my course so benign when I qualified for the very worst outcome..
The answer was I was on Vascepa..Vascepa is an omega-3 EPA which has the effect on modulating and moderating systemic inflammation..I was on 4 gms/day and it kicked the crap out of the puny viruses. Without the inflammatory system to aid them, the viruses were harmless...
":>) JL
new2theparty...
Your questions...1) How does the the purifier distinguish between the bad guys (viruses and malignancies)...from the good guys??
Ans: it doesn't. The exosome cargo is mainly information in the form of proteins and nucleic acids. Once the cloaking material, exosomes and sugars, are removed then the foreign proteins and nuclear sequence are destroyed by the immune and inflammatory systems. Because the material is identified as "non self". Proteins which are "self" do not trigger an immune or inflammatory response..
Please understand (most people including the clinicians don't) The presence of the virus is not the whole story and indeed is probably not even the most important. It is the response of the bodies immune and inflammatory systems to the viruses. As the contagion spreads more viruses spread throughout the body and the inflammatory system goes into overdrive and patients die from something called a "cytokine storm" which is really the inflammatory system gets out of control. That is why it is important to destroy the viruses before they get into the "log phase" or before they get into distant cells...
Hope this helps...
Nice day in a nasty market ..AEMD strong..
":>) JL
AEMD sounds amazing but i have a couple questions:
how does the purifier distinguish between a particle carrying a "message" spreading a disease vs all the other particles carrying on normal functions that contribute to cellular health?
If all particles are scrubbed during treatment, how do you keep a cancer cell or somesuch from blasting out another round of particles as soon as treatment stops?
I'm trying to understand how the treatment process works over time.
Re AEMD...
I really like this stock. One thing biotech players understand is the terrible effect of time. And how it takes its toll as the FDA rolls on and seems to throw one barrier after another until as Shakespeare notes "till the last syllable of recorded time"...AEMD may catch a break (and so will we) because the purifier is not a drug (Its a "device")..and in the FDA, devices run faster than drugs...Plus there is a Lazarus effect. the ability of a drug to bring back patients that physicians consider terminal. Takes shorter time frames and fewer patients..
A drug which is confirmed to cure Rabies or Glioblastoma could be green lighted through the FDA "marketing process" While a cure for Acne could take years and many thousand patients..The fact the hemo purifier has already shown it could effectively salvage one COV-19 patient who was deemed terminal...A patient who later walked out of the hospital..Is a big deal. The purifier is being tried on a limited number of very sick Covid patients. We should see the results in the up coming months (or maybe weeks) and that could light a huge fire under this stock...
":>) JL
jasbg
Bingo shares. 42,000...Taking it up the pipe today...Bingo's Optical system is getting rave reviews from everyone in the field and they have plenty of cash...We need a TPST type short squeeze to get these vultures off the PPS..
":>) JL
Aethlon Medical Inc (AEMD)
4.27 ? 0.03 (0.71%)
Volume: 219,866 @07/09/21 7:55:36 PM EDT
Bid Ask Day's Range
4.0 4.27 4.16 - 4.32
AEMD Detailed Quote
JL, 50 shares of AMRN - pushing your luck here - have to say :)
How many BNGO do you own (and where did you get in) just out of curiosity :)
AEMD is the future...
I have 30 positions in the market and most of them are in the biotech sector...Not all..but most..
Of all these positions I consider AEMD as the one with the greatest potential...How could that possibly be the case?
The answer is that AEMD's addresses the issues of viral contagion and metastases. Viruses are very puny things...So to become unsuccessful parasites..;ie contagion, plagues, pandemics etc that kill its hosts. They must not only be able spread by contact or in the air..They must also be able to spread internally through the hosts and to do this they must be able to use the circulation. Viruses in their naked state can not effectively travel in the circulatory system..as they are identified by the immune system as "non self" and they are tagged and and destroyed by the immune and inflammatory systems. So to game the body's protective systems, the viruses must cloak themselves in self "alleles" Two principle ways the viruses circumvent the immune system is first of all use exosomes which are nano sized vesicles in the cytoplasm of the host cells. These exosomes are tiny bubbles which can store or transport biological material which normally would be attacked as (non self) in the blood stream or unwanted chemicals...The second way viruses can cloak themselves is to coat themselves in sugar molecules
The very clever viruses use these "cargo" containers to evade the body's defenses. Malignant cancers also use the tiny containers to deliver their DNA and RNA into host cells..
What AEMD's purifier does is it removes the exosomes (and sugar molecules) from the circulation and this stops the transport of viruses and neoplastic genetic information in the bloodstream...
":>) JL
What’s funny is this hit 11.00. What a joke. Sub 2.00. Dilution n
What is great about AEMD....
I see no flashing red lights for AEMD...Their clinical research is a little bit difficult to understand, but if you do understand it..It is compelling and has the potential to treat very serious conditions which are lethal and at present can not be treated by other methods. we are talking cancer and viral contagions. These are not trivial and there are no current alternatives..
Aethlon's purifier attacks viruses and malignancies by neutralizing them when they are in transit in the blood stream.. Viruses use the vascular system to go systemic (spread to other tissues). Viruses can not spread in their natural state; Naked viruses without protective covering are identified as foreign protein (Non self) and are quickly deactivated by the body's immune and inflammatory systems. To overcome this problem viruses and cancers can employ strategies which cloak the pathogens in a protective cover. Examples of these are viral transport in Exosomes which are Nano sized vesicles found in the host cytoplasm. Exosomes are like cargo holders which can transport viruses and DNA and RNA..Out of the cell..into the bloodstream and into distant host cells while exhibiting a "self" signature to the immune and inflammatory systems..
Viruses can also fool the immune system by coating themselves with sugars....AEMD's purifier has been shown to effectively remove the exosome and sugar cloaking from the viruses and cancer cells..I am unaware of any other company using these space age medical technologies..
Though I can not predict the future I can imagine the FDA green lighting this technology simply because there is nothing that comes near this in therapeutic scope...
Disclosure..I put nothing beyond the stupidity of the FDA,
":>) JL
1,266,979 O/S March 2019 -15,365,490 O/S June 21, 2021
1200% SCAM CERTIFIED
This AEMD SCAM HAS HAD YEARS TO PRDUCE. THIE ONLY THING THIS DILUTED POS PRODUCES IS SHARES…MORE THAN A 1200% INCREASE IN THE LAST 2 YEARS
Perhaps one should have taken a few more math classes at MIT and Harvard. To those of us that could only bribe our way into a G.E.D., maybe a second review of the facts will help for those super educated though failing in basic 4th grade math skills.
1,266,979 O/S March 2019
4,779,114 O/S Dec 2019
9,367,171 O/S March 2020
12,123,524 O/S Dec 2020
15,365,490 O/S June 21, 2021
OVER A 1200% INCREASE IN THE O/S…(in 2 years)
The MIT alumni office may offer some type of post graduate tutoring for those graduates in need.
I don’t care much about the share structure of other biotech companies. How many other biotech are promoting a glorified Fram oil filter ? No slight to Baldwin filters intended…
AEMD GARBAGE DILUTED SCAM
Quote
"Textbook dilution in this overhyped Hemopurashit."
Couple of real geniuses. I do appreciate your attempts to get the PPS lower as I am in the market for more stock in this issue..
Your comments tell me you have no knowledge in the medical field..I unlike you am a graduate of MIT and Harvard Med with decades of expeience in medical research and clinical medicine. My take on this is the science of the purifier is very compelling and I do not see years of future Phase 2 and phase 3 incarceration in the FDA before they get the go ahead in the clinics...The reason I say this is plausible indications for this therapeutic modality is serious {lethal) viral infections and possibly blocking metastatic carcinoma..
The FDA can be and usually is a great impediment to medical research because the FDA's initial charter was to counter the flood of patent medicines most of which were not only Homeopathic but actual harmful in the early 20th century. The FDA does act off risk vs benefit...In this case the potential benefit is exceptional. The purifier has successfully salvaged patients with COV-19 who were deemed unsalvageable...And that is a very big deal. Clinicians who work in ICUs (Intensive Care Units)
Become very adept at who will survive and who wont...And it is very much more likely you will have a patient who you think is going to survive who doesn't.. Than have a patient you think is terminal ends up surviving..
There is much BS in the biotech world. Latest is the Biogen "cure" for Alzheimer's...I see them all the time. But I do believe that AEMD's device is very real and I agree with Time Magazine.." this is one of the great inventions in medicine."
PS. about dilution AEMD has about 16 mil common shares...The average biotech has more than 160 mil shares.. Why don't you you do a little fact checking before spewing the BS...
Textbook dilution in this overhyped Hemopurashit.
1,266,979 O/S March 2019
4,779,114 O/S Dec 2019
9,367,171 O/S March 2020
12,123,524 O/S Dec 2020
15,365,490 O/S June 21, 2021
OVER A 1200% INCREASE IN THE O/S…(in 2 years)
Garbage
Yes, a real dilution Hemopurashit machine only to enrich the insiders.
This stock is a joke
Lol. Dilution till sub 2.00. What a joke here
The insiders are buying, I am also, just bought 2000 shares!
AEMD'Hemo purifier device...and why it is a potential game changer...
I like to keep up in medical science..but I admit I was not up the pathophysiology and the impact that AEMD's "Hemo Purifier"could have on clinical medicine...
There is an enormous gap between medical science and clinical medicine.
Clinicians. The doctors you see are largely retro and make no pretense in terms of keeping up with medical science. In fact the Hippocratic Oath inveighs against treatments that are novel...The oath says "Experiment is Perilous". Doctors entering clinical practice are cautioned not to be the first in their territory to try new treatments. Mal Practice forces clinicians to practice "defensive medicine"..Not only does this raise the cost of medicine some 40%...but also retards medical progress but costs lives..The only winners is the Med-Mal industry...
AEMD's device is a method of preventing viruses and cancers of spreading by using the blood stream...Both Viruses and cancer cells operate by using their DNA and RNA to alter the host DNA and RNA to produce the viral or the cancers own genetic code to produce viruses or cancer cells. The process is complicated by the fact that the programing genetic sequences must traverse the cell wall of the infected host cell. then enter the bloodstream, then penetrate the cells the cancer or virus they wish to infect.. This is a perilous journey because the genetic material must obey the laws of physics and this means the transported genetic material must present present polar molecules to polar surfaces and non polar molecules to non polar surfaces..
The viral or cancer cell need help and they get it from nano sized bubbles in the host's cytoplasm called exosomes.. the Viruses pack up their genetic material for the trip outside the cell,,into the blood stream and into the cell they wish to infect..These tiny bubbles are are optimally designed to be transport carriers and without them the virus or the cancer cell can not spread. Because the cancer cells or viruses would be destroyed in the blood stream without the protection of the exosomes..
What AEMD's hemo purifier does is it stops "destroys" the exosomes in the bloodstream.. This leads to the viruses and cancer to be vulnerable to the bodies immune and inflammatory systems..This should work with all viruses and cancers .
THAT IS WHY THIS IS VERY BIG DEAL...
":>) JL
Harbor6460...
Quote "This is such a joke. Look at the bagholding. Sub 3.00 soon. Dilutiin machime. And no real fda data. 6 people. Lol"
Laughing at your own jokes? Don't think you'll make it as a "standup". starvation is a horrible way to go. Hope you are not actually investing real money in the stock market..Hate to see you lose your allowance...
FYI...Time Time Magazine named the Hemopurifier to be one of the "Top 25 Inventions" as well as one of the "Eleven Most Remarkable Advances in Healthcare." I fully agree with Time Magazine.
I am an MD with decades of clinical experience and have been involved in major medical research with intuitions like Mass General a major Harvard
teaching hospital..Was involved in the development of the intra aortic balloon pump..A device that was developed in the late 60s and is still saving lives.
AEMD is involved in treating viruses and cancer by control of exosomes..this is real space age stuff and definitely at the vanguard of medical research..And they have actually used the device on real patients with real diseases..And take my word for it you don't need thousands of patients to prove significance...When you have diseases which are highly lethal..(eg rabies) even a couple of cures is significant..
As far as a dilution machine...Well the company has less than 16 million
float...not even one tenth of the average biotech....
AEMD is definitely a hidden gem....
":>) JL
This is such a joke. Look at the bagholding. Sub 3.00 soon. Dilutiin machime. And no real fda data. 6 people. Lol
Dude'''
Nice to hear from you..Amarin's problems are not in the scope of medicine or pathophysiology..Vascepa is arguably one of the greatest drugs ever.
But the company's problem were related to our regulatory drug system and politics. John Thero and the senior management displayed no skill what so ever and made errors and enemies in the government and in the FDA. The only skill Thero and Kennedy displayed was to loot Amarin's chauffer's to feather their own nests. A great example was provided by North who has ties to J&J...J&J had one entire floor which was nothing but Lobbyists..Amarin never heard the word...Maybe the new CEO can work miracles...
Trying the patent case in the Ninth District...Instead of Texas. Was the business equivalent of Napoleon's Russian campaign. I have nothing to contribute to the Amarin board...and currently own 50 shares of AMRN..
":>) JL
JL
I hope you are well! You are missed over on the Amarin board. After you left there was a void of medical information and explanations so I did what I could to fill the void. I put together a paper last October and have since updated it to explain what you have discussed here about the inflammatory response to COVID. I would appreciate any constructive criticism as well as pointing out any errors in what I have compiled from others such as yourself.
See: https://docs.google.com/file/d/13dd7yIWqfdk0FlwUKRH32DJs3zAhe8zh/edit?usp=docslist_api&filetype=msword
Take care
The Dude
edit...Exosomes and the Cov Viruses..( how AEMD fits into the picture)..
The history of medicine is the history of guesses. Some good some not..
A med school professor once said; The questions in medicine do not change..... Only the answers."
For most on medicine's history therapies were determined by what I call the "peanut butter and jelly" method..
That is you line up 100 monkeys with a disease and you give each of them each something different to eat. If all of the monkeys die except the ones who got peanut butter and jelly..Then peanut butter and jelly was the treatment. Why and how PB and J cured the disease was not important. This method led to numerous mistakes and frequent failures, but had to suffice..in a world where "science" was more like guessing..
We are getting better and the one positive of these destructive viral pandemics is they do force the medical field to dig deeper into the disease process. And these Cov Viruses are improving our knowledge by forcing medical science to understand how primitive life forms can use the genetic language to bypass all our Pentagon of inflammatory and immune systems. and end of injuring us or killing us. The only saving grace is they force us to understand our inner workings at least as well as these microbes..
The Cov-viruses are pushing medicine and pathophysiology into a new era...
Unlike primitive man we are not threatened by lions and tigers. Instead We are being attacked by by an enemy so small that we couldn't even see them before the electron microscope. They are are puny, but clever and defeat us by the only way they could beat us..and that is to use our arsenal of defense against ourselves..
The viruses are not killing us. We are killing ourselves..The bugs do not eat us. They defeat us in the only way we can be defeated and that is by tricking our our immune, inflammatory and coagulation systems to turned against ourselves..
I am 80 years old...In Nov last year I tested positive for Cov 19..I looked for signs or symptoms of my disease. but honestly even though I am the very highest cohort for serious disease ..Old age with a history of an MI five years ago..and a pulmonary embolus 4 years ago..I only had one day where my temperature was over 100F...a slight runny nose..and that was it..
Why was I let off so easily?...Well its not the virus. Its your own protective systems inflammatory, immune, and coagulation that go after your heart, lungs and most of the rest of your body's tissues. The only possible explanation IMO was my protective systems particularly inflammation was being moderated..The virus was not able to ramp up my inflammatory system...At the time I was taking 4 gms of Vascepa,,a drug which is pure EPA an (omega three) which is known to moderate systemic inflammation..IMO this largely prevented the virus from turning up my inflammatory system to the point it was attacking the host..IE me,,,
I'm not sure whether or not AEMD has a high "Peanut butter and Jelly" factor or whether they are are on the vanguard of medical science studying exosomes Exosomes are cool things..Kind of the body's form of Amazon..They take orders and ship out cargo... They start out as tiny Nano sized hollow bubble like containers in the cytoplasm that can ship things inside and outside of the cell and convey the cargo into other cells. Via the blood stream and the lymphatic system.
Biological particles include not only the viruses themselves, nucleic acid fragments capable of effecting cellular function, including apoptosis...but these active particles must obey the rules of simple chemistry and physics. polar interfaces inhibit non polar transport and vice versa..So the body uses these nano sized particles (exosomes) to solve transportation in the blood stream and across cell membranes.
It appears that viruses also have accounts in these tiny bubbles..They can use them for transportation to other cells..or ship active genetic material which create for both propagation or control of the hosts systems..
Apparently in cases like the Covid viruses they have learned how to use these exosomes to transport not only the viruses but Nucleic acid sequences that can effect host cells..
Exosomes are going to be a very big thing in medicine this century.. though they are not in general circulation in medicine at present..The stock market is difficult to predict as are biotechs. But AEMD has the potential to be something big..If it can hold its postion as a leader in exosome pathophysiology..
":>) JL
Exosomes and the Cov Viruses..(and how AEMD fits into the picture)..
The history of medicine is the history of guesses..Some good some not..
A med school professor once said the questions in medicine do not change..... Only the answers.
For most on medicine's history therapies were determined by what I call the "peanut butter and jelly" method..
That is you line up 100 monkeys with a disease and you give each of them each something different to eat. If all of the monkeys die except the ones who got peanut butter and jelly why got better...Then peanut butter and jelly was the treatment..How it worked was not important..That resulted in lots of bad medicine..for example boiling oil on amputation stumps..bleeding for heart conditions etc...
Well we are getting better and the one positive of these destructive viral pandemics is they do force the medical field to dig deeper into the disease process. And these Cov# Viruses are improving our knowledge by figuring out how the primitive ?life? forms can use the genetic language to bypass all our Pentagon of inflammatory and immune systems. and end of injuring us or killing us. The only saving grace is they force us to understand our inner workings at yeast as well as these microbes..
The Cov-viruses are pushing medicine and pathophysiology into a new era...What are we learning?
We are not threatened by lions and tigers. We are being attacked by by an enemy so small that we couldn't even see them before the electron microscope. They are are puny, but defeat us by the only way they could beat us..and that is to use our arsenal of defense against ourselves..
They are not killing us. We are killing ourselves..The bugs do not eat us..It's our immune, inflammatory and coagulation systems turned against ourselves..
I am 80 years old...In Nov last year I tested positive for Cov 19..I looked for signs or symptoms of my disease. but honest even though I am the very highest cohort for serious disease ..Old age with a history of an MI five years ago..and a pulmonary embolus 4 years ago..I had one day where my temperature was over 100F...a slight runny nose..and that was it..
Why was I let off so easily?...Well its not the virus..Its your own protective systems inflammatory immune and coagulation that goes after your heart and lungs..And I was taking Vascepa which is a drug which lowers systemic inflammation. In my case my SI was supressed enough that it could not "eat me"...
I'm not sure whether or not AEMD has a high "Peanut butter and Jelly" factor or whether they are are on the vanguard of medical science studying exosomes Exosomes are cool things..Kind of the body's form of Amazon..They take orders and ship out cargo... They start out as tiny Nano sized hollow bubble like containers in the cytoplasm that can ship things inside and outside of the cell and convey the cargo into other cells..
It appears that viruses also have accounts in these tiny bubbles..They can use them for transportation to other cells..or ship active genetic material which create for both propagation or control of the hosts systems..
Exosomes are going to be a very big thing in medicine this century.. though they are not in general circulation at present..The stock market is difficult to predict as are biotechs. But AEMD has the potential to be something big..If it can hold its postion as a leader in exosome pathophysiology..
":>) JL
Quote "AEMD ready for another big run IMO"
Certainly possible...Check out my last June 16th post regarding AEMD and Biogen. BIIG won the hoopla award hands down...but look at which issue AEMD or BIIG..is winning the money race. I think AEMD has employed its exosome cleaner in some other locales (as yet disclosed) and am guessing they are very pleased with the results. That would be consistent with what the PPS is telling us...
":>)JL
AEMD ready for another big run IMO.
Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021
June 21 2021 - 03:27PM
PR Newswire (US)
SAN DIEGO, June 21, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2021, ended March 31, 2021, at 4:15 p.m. ET on Thursday, June 24, 2021.
Management will host a conference call on Thursday, June 24, 2021 at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.
Interested parties can register for the conference by navigating to https://dpregister.com/sreg/10157771/e9dc23c656. Please note that registered participants will receive their dial in number upon registration.
Interested parties without internet access or unable to pre-register may dial in by calling:
PARTICIPANT DIAL IN (TOLL FREE): 1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442
All callers should ask for the Aethlon Medical, Inc. conference call.
A replay of the call will be available approximately one hour after the end of the call through July 1, 2021. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll free at 1-855-669-9658. The replay conference ID number is 10157771.
About Aethlon and the Hemopurifier®
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.
The Hemopurifier® is an FDA designated "Breakthrough Device" related to the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. Under an Investigational Device Exemption (IDE) application, in October 2019, the FDA approved an Early Feasibility Study (EFS), which is the device equivalent of a Phase 1 clinical trial for a drug or biologic, in a single center, open label trial in 10 to 12 subjects. The study is evaluating the HEMOPURIFIER® for reducing cancer-associated exosomes prior to the administration of standard-of-care pembrolizumab (KEYTRUDA®), which is a first-line therapy for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. The EFS is being conducted at the University of Pittsburgh Medical Center Hillman Cancer Center.
The Hemopurifier also holds a Breakthrough Device designation related to life-threatening viruses that are not addressed with approved therapies. In June 2020, the FDA approved an amendment to the Company's existing open IDE for the Hemopurifier in life threatening viral infections, to allow for the treatment of patients with SARS-CoV-2/COVID-19 infection. This will allow for up to 40 of these patients to be treated under a new Early Feasibility Study protocol at up to 20 clinical sites in the U.S.
Aethlon also owns 80% of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression. Additional information can be found online at www.AethlonMedical.com and www.ExosomeSciences.com.
Company Contact:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com
Media Contact:
Tony Russo, Ph.D.
Russo Partners, LLC
tony.russo@russopartnersllc.com
212-845-4251
Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com
212-966-3650
Cision View original content:http://www.prnewswire.com/news-releases/aethlon-medical-to-release-fourth-quarter-financial-results-and-host-conference-call-on-june-24-2021-301316674.html
SOURCE Aethlon Medical, Inc.
Copyright 2021 PR Newswire
Two filtration companies have made serious advancement with the FDA. AEMD with their two FDA breakthrough designations and a very quiet little company based out of Toronto called Spectral Medical. It barely trades on the OTC and not too much more in Toronto as T.EDT. They are in a phase 4 confirmatory trial for Sepsis with 28 day mortality as the endpoint and massive inside ownership as the model. Good luck to both these science sultans!
FWIW ...the FDA is formulating near half of EDTXF's final data for the confirmatory trial using data from the phase 3 that was originally billed as a "FAILURE". Spectral was also granted the ability to use a 2 to 1 ratio in favor of their product in the confirmatory trial. Pay close attention to anonymous types wearing camo and trading where they can't be taken seriously.
The other problem with Biogen is the price point for a regimen. Way too expensive for the health care system.
AEMD's problem is its long history of trying to garner attention from the medical field with their limited financial resources. With their challenges over the years, there was rising short interest. The sharp spike in reaction to their news was partially due to short covering and the decline is reestablishing those short positions a higher prices.
Investors in biotechs have a tendency to suffer from ADD. Patience is not their forte.
Look at the low float stocks they run that are pure crap. They ran the O stock today. No news nothing. AEMD has solid news and analyst upgrades. Any day now they should run us up to higher highs than we saw last week with ease IMO. Shorts ladder walked us down to get all stop losses and weak hands out and it was overkill on the way down. Time to overkill them on the way up. If the O stock can be pushed over $20.00 on nothing we surely can do the same soon.
Nub...
I don't know how much experience you have in investing in biotechs..They can be extremely volatile and you have a lot of people including funds who don't know the science and medicine and probably should not be investing in this sector..
In the case of AEMD this advice should be doubled..at present I present two stocks..one is BIIB Who has recently got an FDA accelerated semi approval for an Alzheimer's drug...The approval came after an "Adcom" where the panel acknowledged that Biogen's drug did clear up some of the Beta amyloid which is a calling card of AD...This looks great but the trouble is there is no compelling evidence that removing Beta-Amyloid will improve the symptoms of AD...
The second issue is AEMD..In its latest chapter AEMD's plasma purifier was used in two patient with COV-19 both in dire straights and considered terminal (not going to live) and one of these patients actually walked out of the Hospital and went home after the AEWMD treatment..
Now which of these should you believe. The BiiB result resulted from a Peer reviewed study with a lot of patients. The second was from a small company with no intent other than to try to save a life or two in which clinicians were convinced there were no other options. Most would focus on the Biogen trial..IMO that is a huge mistake. I am much more impressed by AEMD's result than Biogen's. I have a long history in clinical medicine and medical research and I know how hard it is to save a patient when the consensus of the clinicians are that the patient is going to die. And further more considering the pathophysiology..in this case I understand how the AEMD treatment worked and am convinced this is no fluke...And that's why I am invested in this stock and have puts on Biogen...
So I do not care if the PPS is going down because I will be buying more stock when the price drops..I feel confident AEMDs treatment is the real McCoy...
Please understand I am not a qualified financial advisor and this is only my opinion and you should do your own Due Diligence..
Best of luck...":>) JL
jessellivermore,
I still don't understand how someone paid 12.4mil worth of stock at $9 just to watch it go lower and lower..red market is understandable but this ticker heading south way too obvious..
StockNewbie,,,
When the cops raid the Whore House they take the piano player in with the hookers..
Yesterday only one of my 28 positions was green,, MARA a crypto stock,,the rest were down...So no surprise that AEMD was "bleeding" along with all of the others..I call it "Bi den wait for the market to drop"...
":>) JL
cj,,,
You getem Cujo..Rip their throats out..
LOL...":>) JL
There were more than 2 patients tested this is another myth they have many studies going. 150 patients in one from what I remember. AEMD is going to run another couple hundred percent above soon IMO and crush all stop loss traders and weak handed panic sellers as we squeeze these shorts into bankruptcy ahead soon IMO.
AEMD...
On Yahoo...some poster criticized the fact that AEMDs "purifier" which was used on two terminal patients in the last stages of COV 19 (one of the two patients recovered and was discharged) was Quote "Not peer reviewed..and was worthless".
This individual thinks he is an expert on all things AEMD and is bearish does not understand what happened..
It is true the fact one of two patients considered terminal. did survive does not suggest this is a Peer reviewed Clinical trial. The design here was not like a Phase 3 clinical trial studying efficacy. This was compassionate use of AEMD's purifier in a situation that FDA agreed both patients were terminal, and there was no other options...
The fact one of these patients survived is in my mind very promising. When I was in med school I got summer job working at Avco Everette Research labs. Which were working in conjunction with Mass General on the Intra Aortic Balloon Pump. That was back in the mid 1960s..The early use of the balloon pump at the Mass General Hosp.at The Brigham, both Harvard Hospitals in Boston and Maimonides in Brooklyn...Were pretty depressing.. We were also working on terminal patients with terrible hearts and none of our original patients survived..
The balloon pump is still an use and has saved thousands of patients. And believe me we never batted 50% in our first two patients...
":>) JL
Excellent Pedro! What an amazing past several months it's been! Let's keep 'em flowin' right cheers>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$
GM subs excellent stuff, thanks much for sharing that great feedback!
doogi I met with several investors today and explained to them the relationship in connecting the dots. Hope you had a sweet weekend buddy!!
The AEMD filings hit late Friday on the $9.00 per share offering that is now closed. We have a tiny float and OS and we have a majority shareholder of the company who owns at $9.00 per share. Time to run to $15.00 to $20.00 this week ahead we need to get rid of all stop loss traders to get he massive short positions to cover.
Hey, Bro...how are you? I'm in waiting for the rocket to ignite.
AEMD.....
My new favorite....
To those of you who do not know me..I am a grad of Harvard Med School with a Chem E degree from MIT...
This is a very cool situation..(Better by far than the phony Biogen drug recently Oked BY the FDA for treatment of AD,,Approved after an AdCom which failed to show the drug had any clinical benefit. and was going to cost $56K per individual annually..
AEMD is probably going to be slow to be adopted by the market as it is complicated, but the clinical effects are mind blowing..
The physiological benefits involve the actions of "exosomes" that only a small fraction of med students or grads are familiar with..The subject deals with Access..Complex life forms like mammals..Have to deal with two separate and non compatible chemical interfaces which are polar (they have positive or negative charges) or non polar interfaces.. Polar and non polar do not mix.. We know this as oil and water...Water is polar and oil is non polar..Viruses like Covid require the protection of lipid cover to exist in the cell cytoplasm..to transport out in the blood stream and they find this cover in microscopic "vesicles" which in lay terms are bubbles found in the cytoplasm of the host cells..These are called exosomes..Inside the exosomes the virus can survive and be transported in the blood stream..The virus is not doing any great harm if it is floating around in the circulation..what does happen is the virus can be conveyed to the cell membrane surface and the exosomes have the correct structure to penetrate the cell membrane and deliver the virus into the cell where it does the damage..
What AEMD's plasma purifier does is to add an agent which destroys the exosomes' membrane which throws the viruses into the blood stream where it can not penetrate the cell membrane and are neutralized (killed) by the immune and inflammatory systems...
This is the real McCoy......The amazing potential here is that exosome disruption should end the career of any of these or future viral outbreaks and pandemics...
":>) JL
Followers
|
233
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
18521
|
Created
|
11/19/04
|
Type
|
Free
|
Moderators |
At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses,
the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies.
The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure cloaks these targets from immune detection.
At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc.,
a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical,
is focused on the discovery of exosomal biomarker candidates to diagnose and monitor life-threatening diseases.
The proprietary Enzyme-Linked Lectin-Specific Assay (ELLSA™) serves as a platform to isolate exosomal biomarkers from a wide-range of bodily fluids.
In preliminary studies, ELLSA™ demonstrated the ability to isolate exosomes from urine, which resulted in high-sensitivity detection of HIV-infection.
Specific to neurological disorders, Exosome Sciences discovered TauSome™, an exosomal biomarker that may be the first non-invasive candidate to
detect Chronic Traumatic Encephalopathy (CTE) in living individuals. In a study of former National Football League (NFL) players,
TauSome levels were found to be significantly higher as compared to athlete control subjects who participated in non-contact sports.
TauSome levels also correlated with cognitive decline based standardized tests of memory and psychomotor speed. Visit www.exosomesciences.com for additional details.
Time Magazine named the Hemopurifier® a "Top 25 Invention" and a "Remarkable Advance in Healthcare" based on its use in treating Ebola virus.
Emerging pathogens pose a significant threat to mankind. Of the hundreds of viral pathogens known to be infectious to man, only a few are addressed with
proven antiviral drug or vaccine therapies. Beyond the looming threat of bioterrorism, a proliferation of international travel, urban crowding and global warming
is expected to accelerate the emergence of future pandemics. In response, the U.S. Department of Health and Human Services (HHS) has established an initiative
to support platform technology medical countermeasures with broad-spectrum capabilities. Based on preclinical studies and human treatment experiences, the Aethlon Hemopurifier® defines this initiative.
To date, Hemopurifier therapy has been administered to individuals infected with Ebola virus, Hepatitis C virus (HCV) and the Human Immunodeficiency virus (HIV).
In the case of Ebola, a remarkable response to a single administration of Hemopurifier therapy (comatose physician with multiple organ failure at the time), led to
Time Magazine naming the Hemopurifier to be one of the "Top 25 Inventions" as well as one of the "Eleven Most Remarkable Advances in Healthcare."
Beyond human treatment experiences, pre-clinical Hemopurifier studies have validated the broad-spectrum capture of numerous viral threats.
These include: Chikungunya, Dengue and West Nile virus, as well as Vaccinia and Monkey pox, which serve as models for human Smallpox infection.
Specific to pandemic influenza threats, Aethlon has validated the capture of H5N1 avian flu, H1N1 swine flu, and the reconstructed 1918 influenza virus,
which represents a model for the strain of influenza that killed an estimated 50 million victims in 1918 and 1919. In vitro studies of other viral threats are ongoing.
https://coronavirus.jhu.edu/map.html
================================================================================================================================================================================
================================================================================================================================================================================
================================================================================================================================================================================
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads